Abingdon Science Park is recognised as an innovative research and development location within the Oxford science and technology cluster. With plans to expand the Park, Kadan’s acquisition of the scheme will help to cement the science and technology industry within Oxfordshire and plays a crucial role in supporting the UK as a global exporter of R&D innovation post-Brexit.
The Quadrant, located on Abingdon Science Park, is home to companies including a world-leading cancer gene therapy company and data science firms. The work taking place on the park is boosting the science and tech industry across the Oxford to Cambridge Arc.
The Quadrant was acquired from Addington Capital, an investment management firm, for £13.475m and a net yield of 6.7%, securing an advantageous deal for both parties.
Kadans’ deepening interest to secure exposure to the UK’s science and techsector proves that the Oxford toCambridge Arc is the place to invest.As part of the deal, Kadans also bought 1.59 acres of land with planning permission for another 20,000 sq ft of laboratoryand office space.
This deal builds on Bidwells’ market presence in Oxford, a city widely considered a global centre of excellence in life science innovation, which has been bolstered by a string of high-profile acquisitions over the last few years.
Get in touch with our team
Saul Western
Partner, Head of Commercial
Providing thorough and professional investment advice across the golden triangle and beyond.